Atlas Trials

Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome

Clinical trial NCT05221021 · RECRUITING

Trial details

NCT number
NCT05221021
Sponsor
Walter Reed National Military Medical Center
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Overactive Bladder Syndrome
Start date
2022-10-01
Primary completion
2026-12-30
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.